Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Uterine Cervical Neoplasms × Therapeutics × Clear all

Phase

Status

Sponsor Class

OTHER 3 OTHER_GOV 1 NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Polycystic Ovary Syndrome 1 Pain 1 Obesity 1 Infertility 1 Head and Neck Neoplasms 1 Depression 1 Anxiety Disorders 1

Interventions

Cisplatin 4 Radiotherapy 3 Hydralazine 3 Gemcitabine 3 Valproic Acid 2 Probiotics 2 Paclitaxel 2 Drug Therapy 2 spartalizumab 1 nimotuzumab 1 belotecan 1 apatinib 1 Therapeutics 1 Surgical Procedures, Operative 1 Standard of Care 1 Radiotherapy, Intensity-Modulated 1 Radiation Dose Hypofractionation 1 Proto-Oncogene Proteins c-raf 1 Neoadjuvant Therapy 1 Mobile Health Units 1 Magnetic Resonance Spectroscopy 1 Magnesium 1 Injections 1 Immune Checkpoint Inhibitors 1 Hysteroscopy 1 Heart Rate 1 Fatty Acids, Omega-3 1 Early Intervention, Educational 1 Diet Therapy 1 Curcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07181278 2025-12-02

OptiTri_MT

Institut de Recherche pour le Developpement

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡